Amicrobe, Inc.â is an advanced biomaterials company with innovative product candidates designed to prevent and treat infections. Amicrobe biomaterials are engineered to provide better tissue coverage and broad antimicrobial activity. These novel, synthetic biomaterials can be formulated as solutions, emulsions, hydrogels, and fiber-based products to constitute or enhance a variety of healthcare products that address dangerous and costly infections. The Companyâs new, synthetic block copolypeptides (A-Blocks) are engineered to provide broad antimicrobial activity and superior tissue coverage when our natural barriers of defense are broken in surgery, trauma / burns, and diabetic foot ulcers The Company has developed two lead A-Block series: AB-100L for antimicrobial barrier gels and AB-100rL for anti-infective solutions and emulsio
